The CeMM Library of Unique Drugs (CLOUD) is the first condensed set of FDA-approved drugs representing all clinical compounds. Its potential was shown in a combinatorial high throughput screen at the CeMM chemical screening platform, published in Nature Chemical Biology: by testing all CLOUD compounds in combination with each other, a pair of hitherto unrelated drugs proved to be highly effective against multiple prostate cancer cell lines known for their resistance to therapy.